Zhou, Yuan
Cai, Song
Gomez, Kimberly
Wijeratne, E. M. Kithsiri
Ji, Yingshi
Bellampalli, Shreya S.
Luo, Shizhen
Moutal, Aubin
Gunatilaka, A. A. Leslie
Khanna, Rajesh http://orcid.org/0000-0002-9066-2969
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (1R01NS098772)
National Cancer Institute (R01CA90265)
Article History
Received: 3 March 2020
Accepted: 4 May 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: Not applicable.<b>Ethics approval for use of animals</b>The University of Arizona’s College of Medicine Institutional Animal Care and Use Committee (IACUC) sanctioned all experiments.
: Not applicable.
: R. Khanna is the co-founder of Regulonix LLC, a company developing non-opioids drugs for chronic pain. In addition, R. Khanna has patents US10287334 and US10441586 issued to Regulonix LLC. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.